Novel Prognostic Staging System for Patients With De Novo Metastatic Breast Cancer is a research paper published in Journal of Clinical Oncology (2023). On theSindex it has a DataRank of 0. It has been cited 42 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NICHD NIH HHS
Grant: K12 HD043446
NCI NIH HHS
Grant: P30 CA014236
FWCI
4.45
Citation Percentile
1.0%
Influential Citations
4
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Exosomal miR-361-3p promotes the viability of breast cancer cells by targeting ETV7 and BATF2 to upregulate the PAI-1/ERK pathway
Additional file 1 of Exosomal miR-361-3p promotes the viability of breast cancer cells by targeting ETV7 and BATF2 to upregulate the PAI-1/ERK pathway